Burlington-based Labcorp has launched the first blood-based test cleared by the U.S. Food and Drug Administration (FDA) for ...
A less invasive test for Alzheimer’s is a big advance. But it’s not perfect and is not meant to screen healthy people.
A simple blood test measuring neurofilament light chain, or NfL levels, may help predict the risk of developing brain ...
The International Advisory Committee on Clinical Trials led a multinational panel updating the McDonald criteria, adding the ...
CNSide Diagnostics, a wholly-owned subsidiary of Plus Therapeutics, Inc. (NASDAQ: PSTV), has signed a national agreement with ...
This test is available exclusively through CNSide Diagnostics, LLC. as a testing service provided to health care professionals in the U.S.
For decades, diagnosis of brain cancer has been medicine’s most difficult and hazardous challenge. Simple imaging such as MRI ...
Background: Glucose transporter type 1 deficiency syndrome (Glut1DS) is a treatable neurogenetic metabolic disorder caused by pathogenic variants in the SLC2A1 gene. The relationship between genotype ...
Gov. Spencer Cox of Utah has called for politicians to tone down their rhetoric. The assassination of Charlie Kirk is challenging the limits of that high-minded approach. By Kellen Browning Jack Healy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback